← FDA DRUG APPROVALS

FDA ANDA · ANDA076915

DESOGESTREL AND ETHINYL ESTRADIOL

Sponsor: WATSON LABS

APPLICATION
ANDA076915
TYPE
ANDA
ORIGINAL APPROVAL
2005-07-29
LATEST ACTION
2022-04-29
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DESOGESTREL AND ETHINYL ESTRADIOLPrescription
DESOGESTREL 0.15MG, ETHINYL ESTRADIOL 0.03MG · TABLET · ORAL-28

Approval history

2022-04-29Labeling · Supplement 21 · standardAP
2017-08-09Labeling · Supplement 20 · standardAP
2015-04-13Labeling · Supplement 13 · standardAP
2013-06-28Labeling · Supplement 11 · standardAP
2010-07-28Labeling · Supplement 10AP
2005-07-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →